Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Kirby delivers strong results, expanding services tied to data centers and prudent debt management with reasonable valuation.

US stocks fell sharply on Thursday, led by a decline in tech stocks as the end of the longest-ever US government shutdown was ...

Revenue for 2025 was $11.5 million, reflecting a decrease from $11.7 million for 2025 due to legacy platform migration, ...

Quiq reports on key questions surrounding AI, covering its capabilities, risks, ethical challenges, and future implications ...

PhysicsWallah IPO GMP, PhysicsWallah Subscription Status Live: The wait is finally over for investors looking to participate ...

C3.ai AI and Veritone VERI are two small-cap companies at the forefront of enterprise artificial intelligence software. C3.ai ...

AM Eastern time on Thursday, November 13, 2025 Toronto, Ontario and Chicago, Illinois–(Newsfile Corp. – November 12, 2025) – Medexus Pharmaceuticals ...

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the highest dose level studied to date in patients with refractory metastatic ...

Q3 2025 net product revenues grew to $14.3 million; Q3 2025 total net product revenues were $56.8 millionOperational pilot ...

According to the 2024 Local Shop Report from the Association of Convenience Stores, more than 20% of convenience retailers’ ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...